• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲癌症研究与治疗组织生命质量核心问卷-晚期癌症患者版韩国文化适应性研究。

Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative Care.

机构信息

Department of Family Meidicine, Seoul National University Hospital, Seoul, Republic of Korea.

出版信息

J Pain Symptom Manage. 2011 Feb;41(2):478-84. doi: 10.1016/j.jpainsymman.2010.05.009. Epub 2010 Dec 10.

DOI:10.1016/j.jpainsymman.2010.05.009
PMID:21145697
Abstract

CONTEXT

The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative Care (EORTC QLQ-C15-PAL) is a shortened version of the EORTC QLQ-C30, developed for use in advanced cancer patients.

OBJECTIVES

We evaluated the psychometric properties of the Korean version of the EORTC QLQ-C15-PAL to determine if this tool can be used to evaluate Korean patients with cancer who receive palliative care.

METHODS

A multicenter, cross-sectional survey was performed in palliative care units and hospices in Korea from September to October 2009. A total of 102 patients with cancer completed the questionnaires that included the EORTC QLQ-C15-PAL.

RESULTS

The compliance rate was high, with the missing rate for each item ranging from 0% to 7.8% (mean 3.1%). A multitrait scaling analysis revealed good convergent and discriminant validity, with only three scaling errors. The Cronbach's alpha coefficients ranged from 0.65 to 0.89. The questionnaire discriminated among patient subgroups with different clinical profiles (e.g., performance status and degree of oral intake), thereby demonstrating the clinical validity of this tool.

CONCLUSION

Our findings indicate that the Korean version of the EORTC QLQ-C15-PAL is a reliable and valid instrument with regard to its psychometric properties. This tool is suitable for measuring quality of life, particularly with regard to physical aspects, in Korean cancer patients who receive palliative care.

摘要

背景

欧洲癌症研究与治疗组织生活质量问卷核心 15-姑息治疗版(EORTC QLQ-C15-PAL)是 EORTC QLQ-C30 的缩短版,专为晚期癌症患者使用而开发。

目的

我们评估了 EORTC QLQ-C15-PAL 韩文版的心理测量特性,以确定该工具是否可用于评估接受姑息治疗的韩国癌症患者。

方法

2009 年 9 月至 10 月,在韩国的姑息治疗病房和收容所进行了一项多中心、横断面调查。共有 102 名癌症患者完成了包括 EORTC QLQ-C15-PAL 在内的问卷。

结果

问卷的完成率很高,每个项目的缺失率为 0%至 7.8%(平均 3.1%)。多特质评分分析显示具有良好的收敛和区分效度,只有 3 项评分错误。Cronbach's alpha 系数范围为 0.65 至 0.89。该问卷可区分具有不同临床特征的患者亚组(例如,表现状态和口腔摄入程度),从而证明了该工具的临床有效性。

结论

我们的研究结果表明,EORTC QLQ-C15-PAL 韩文版在心理测量特性方面具有可靠性和有效性。该工具适合测量韩国姑息治疗癌症患者的生活质量,特别是在身体方面。

相似文献

1
Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative Care.欧洲癌症研究与治疗组织生命质量核心问卷-晚期癌症患者版韩国文化适应性研究。
J Pain Symptom Manage. 2011 Feb;41(2):478-84. doi: 10.1016/j.jpainsymman.2010.05.009. Epub 2010 Dec 10.
2
Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.欧洲癌症研究与治疗组织QLQ-C15-PAL问卷在中国内地的跨文化验证
Palliat Med. 2016 Apr;30(4):401-8. doi: 10.1177/0269216315593671. Epub 2015 Jun 29.
3
Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.验证用于评估姑息治疗患者健康相关生活质量的 EORTC QLQ-C15-PAL 问卷的墨西哥西班牙语版。
Psychooncology. 2011 Aug;20(8):889-96. doi: 10.1002/pon.1801. Epub 2010 Jul 26.
4
Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer.欧洲癌症研究与治疗组织老年癌症患者QLQ-ELD14问卷韩文版的跨文化应用
J Geriatr Oncol. 2017 Jul;8(4):271-276. doi: 10.1016/j.jgo.2017.03.001. Epub 2017 Apr 1.
5
Independent Validation of the Japanese Version of the EORTC QLQ-C15-PAL for Patients With Advanced Cancer.欧洲癌症研究与治疗组织(EORTC)QLQ-C15-PAL日本版在晚期癌症患者中的独立验证
J Pain Symptom Manage. 2015 May;49(5):953-9. doi: 10.1016/j.jpainsymman.2014.11.299. Epub 2015 Jan 13.
6
Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.约旦癌症患者中欧洲癌症研究与治疗组织核心生活质量问卷C15-PAL阿拉伯语版的心理测量学特性
Support Care Cancer. 2016 Jun;24(6):2455-62. doi: 10.1007/s00520-015-3018-9. Epub 2015 Dec 11.
7
The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients.EORTC QLQ-C15-PAL 问卷:西班牙骨转移患者的验证研究。
Qual Life Res. 2014 Apr;23(3):849-55. doi: 10.1007/s11136-013-0511-9. Epub 2013 Sep 4.
8
Reliability and validity of the Turkish version of the EORTC QLQ-C15-PAL for patients with advanced cancer.欧洲癌症研究与治疗组织(EORTC)QLQ-C15-PAL土耳其语版本在晚期癌症患者中的信度和效度
Palliat Support Care. 2016 Dec;14(6):628-634. doi: 10.1017/S1478951516000195. Epub 2016 Apr 12.
9
Verification of the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 palliative (EORTCQLQ-C15-PAL).验证欧洲癌症研究与治疗组织生活质量问卷核心 15 项(EORTCQLQ-C15-PAL)日本版的心理测量特性。
Qual Life Res. 2012 Mar;21(2):335-40. doi: 10.1007/s11136-011-9939-y. Epub 2011 Jun 4.
10
Quality of Life in a Hospice: A Validation of the Croatian Version of the EORTC QLQ-C15-PAL.临终关怀中的生活质量:欧洲癌症研究与治疗组织QLQ-C15-PAL克罗地亚语版本的验证
Am J Hosp Palliat Care. 2018 Aug;35(8):1085-1090. doi: 10.1177/1049909118760781. Epub 2018 Feb 21.

引用本文的文献

1
Validity and reliability of the integrated palliative care outcome scale (IPOS) in Korea: a multicenter study of terminally ill cancer patients.韩国综合姑息治疗结局量表(IPOS)的效度和信度:一项针对晚期癌症患者的多中心研究。
BMC Palliat Care. 2024 Dec 23;23(1):298. doi: 10.1186/s12904-024-01630-0.
2
Depression, performance status, and discontinued treatment mediate an association of curability belief with prognosis in advanced cancer patients.抑郁、身体状况和治疗中断会影响可治愈信念与晚期癌症患者预后之间的关联。
Sci Rep. 2024 Nov 24;14(1):29098. doi: 10.1038/s41598-024-80687-6.
3
Korean Version of the Longer-Term Unmet Needs After Stroke Questionnaire.
《韩国版中风后长期未满足需求问卷》
Ann Rehabil Med. 2023 Oct;47(5):367-376. doi: 10.5535/arm.23044. Epub 2023 Oct 4.
4
Treatment patterns and out-of-hospital healthcare resource utilisation by patients with advanced cancer living with pain: An analysis from the Stop Cancer PAIN trial.晚期癌症伴疼痛患者的治疗模式和院外医疗资源利用:来自 Stop Cancer PAIN 试验的分析。
PLoS One. 2023 Feb 28;18(2):e0282465. doi: 10.1371/journal.pone.0282465. eCollection 2023.
5
Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol.一项多中心、双盲、随机、安慰剂对照试验的原理与设计,旨在研究纳地美定对癌症疼痛患者阿片类药物所致便秘的影响:一项研究方案。
Contemp Clin Trials Commun. 2022 Aug 5;29:100967. doi: 10.1016/j.conctc.2022.100967. eCollection 2022 Oct.
6
Multicentric prospective study of effect of dietary intake on quality of life for patients with end-stage cancers.饮食摄入对终末期癌症患者生活质量影响的多中心前瞻性研究。
Fujita Med J. 2020;6(1):1-6. doi: 10.20407/fmj.2018-023. Epub 2019 Nov 2.
7
Cultural Influences on Complementary Feeding Beliefs amongst New Chinese Immigrant Mothers in England: A Mixed Methods Study.文化对英国新移民母亲在补充喂养信念上的影响:混合方法研究。
Int J Environ Res Public Health. 2020 Jul 29;17(15):5468. doi: 10.3390/ijerph17155468.
8
Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.EORTC QLQ-C15-PAL 在智利姑息治疗服务的晚期癌症患者和医疗保健专业人员中的内容验证。
BMC Palliat Care. 2020 Jun 9;19(1):81. doi: 10.1186/s12904-020-00586-1.
9
The Association of Acculturation and Complementary Infant and Young Child Feeding Practices Among New Chinese Immigrant Mothers in England: A Mixed Methods Study.英国新移民母亲的文化适应与补充婴幼儿喂养实践的关联:混合方法研究。
Int J Environ Res Public Health. 2019 Sep 6;16(18):3282. doi: 10.3390/ijerph16183282.
10
Prevalence of pain and treatment outcomes among cancer patients in a Malaysian palliative care unit.马来西亚一家姑息治疗病房中癌症患者的疼痛患病率及治疗结果
Pharm Pract (Granada). 2019 Jan-Mar;17(1):1397. doi: 10.18549/PharmPract.2019.1.1397. Epub 2019 Mar 18.